{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:50:50Z","timestamp":1788047450583,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.pcad.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:25:25Z","timestamp":1557408325000},"page":"227-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT)"],"prefix":"10.1016","volume":"62","author":[{"given":"Mohita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2019.05.006_bb0005","doi-asserted-by":"crossref","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary. Circulation. 2018;138(13):e210-e71.","DOI":"10.1161\/CIR.0000000000000548"},{"issue":"3","key":"10.1016\/j.pcad.2019.05.006_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jacep.2019.02.001","article-title":"Acute management of ventricular arrhythmia in patients with suspected inherited heart rhythm disorders","volume":"5","author":"Laksman","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003619","article-title":"Outcome of apparently unexplained cardiac arrest: results from investigation and follow-up of the prospective cardiac arrest survivors with preserved ejection fraction registry","volume":"9","author":"Herman","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.pcad.2019.05.006_bb0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/HCO.0b013e32833846b3","article-title":"Recent progress in congenital long QT syndrome","volume":"25","author":"Lu","year":"2010","journal-title":"Curr Opin Cardiol"},{"issue":"16","key":"10.1016\/j.pcad.2019.05.006_bb0025","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/CIRCULATIONAHA.111.055947","article-title":"Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation","volume":"125","author":"Napolitano","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pcad.2019.05.006_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cpcardiol.2008.07.002","article-title":"Long QT syndrome","volume":"33","author":"Goldenberg","year":"2008","journal-title":"Curr Probl Cardiol"},{"issue":"24","key":"10.1016\/j.pcad.2019.05.006_bb0035","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.jacc.2008.02.068","article-title":"Long QT syndrome","volume":"51","author":"Goldenberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.pcad.2019.05.006_bb0040","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/CIRCULATIONAHA.104.494476","article-title":"Molecular basis of arrhythmias","volume":"112","author":"Shah","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2019.05.006_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev.med.49.1.263","article-title":"The molecular genetics of the long QT syndrome: genes causing fainting and sudden death","volume":"49","author":"Vincent","year":"1998","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1016\/j.pcad.2019.05.006_bb0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","article-title":"Long-QT syndrome: from genetics to management","volume":"5","author":"Schwartz","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2796.2005.01583.x","article-title":"The congenital long QT syndromes from genotype to phenotype: clinical implications","volume":"259","author":"Schwartz","year":"2006","journal-title":"J Intern Med"},{"issue":"20","key":"10.1016\/j.pcad.2019.05.006_bb0060","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/CIRCULATIONAHA.111.062182","article-title":"QTc behavior during exercise and genetic testing for the long-QT syndrome","volume":"124","author":"Schwartz","year":"2011","journal-title":"Circulation"},{"issue":"5006","key":"10.1016\/j.pcad.2019.05.006_bb0065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1126\/science.1673802","article-title":"Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene","volume":"252","author":"Keating","year":"1991","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pcad.2019.05.006_bb0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0146-2806(97)80009-6","article-title":"The long QT syndrome","volume":"22","author":"Schwartz","year":"1997","journal-title":"Curr Probl Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2019.05.006_bb0075","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.pcad.2019.05.006_bb0080","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/CIRCULATIONAHA.107.729368","article-title":"Long-QT syndrome after age 40","volume":"117","author":"Goldenberg","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pcad.2019.05.006_bb0085","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pcad.2019.05.006_bb0090","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jacc.2009.11.042","article-title":"Risk of fatal arrhythmic events in long QT syndrome patients after syncope","volume":"55","author":"Jons","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.pcad.2019.05.006_bb0095","first-page":"1185","article-title":"Schwartz PJ. A molecular basis for the therapy of the long QT syndrome","volume":"89","author":"Priori","year":"1996","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"10","key":"10.1016\/j.pcad.2019.05.006_bb0100","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pcad.2019.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCRESAHA.110.218891","article-title":"Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3","volume":"106","author":"Ruan","year":"2010","journal-title":"Circ Res"},{"issue":"13","key":"10.1016\/j.pcad.2019.05.006_bb0110","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/CIRCULATIONAHA.110.950147","article-title":"Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European long-QT syndrome implantable cardioverter-defibrillator (LQTS ICD) registry","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2019.05.006_bb0115","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/0735-1097(92)90253-J","article-title":"Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome","volume":"20","author":"Brugada","year":"1992","journal-title":"A multicenter report. J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.pcad.2019.05.006_bb0120","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/01.CIR.0000104568.13957.4F","article-title":"Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest","volume":"108","author":"Brugada","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2019.05.006_bb0125","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1540-8159.2009.02354.x","article-title":"Prevalence of a Brugada pattern electrocardiogram in an urban population in the United States","volume":"32","author":"Patel","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/HCO.0b013e32831cb920","article-title":"Clinical spectrum of patients with a Brugada ECG","volume":"24","author":"Fowler","year":"2009","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2019.05.006_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European heart rhythm association","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pcad.2019.05.006_bb0140","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.CIR.95.9.2277","article-title":"Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease","volume":"95","author":"Kasanuki","year":"1997","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2019.05.006_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1540-8167.2004.03601.x","article-title":"Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome","volume":"15","author":"Mizumaki","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"10.1016\/j.pcad.2019.05.006_bb0150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/HCO.0b013e32833846ee","article-title":"Genetics of Brugada syndrome","volume":"25","author":"Campuzano","year":"2010","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"10.1016\/j.pcad.2019.05.006_bb0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1540-8167.2001.00680.x","article-title":"Brugada syndrome and supraventricular tachyarrhythmias: a novel association?","volume":"12","author":"Eckardt","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1540-8167.2007.00972.x","article-title":"Influence of meals on variations of ST segment elevation in patients with Brugada syndrome","volume":"19","author":"Nishizaki","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6673","key":"10.1016\/j.pcad.2019.05.006_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/32675","article-title":"Genetic basis and molecular mechanism for idiopathic ventricular fibrillation","volume":"392","author":"Chen","year":"1998","journal-title":"Nature."},{"issue":"8","key":"10.1016\/j.pcad.2019.05.006_bb0170","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European heart rhythm association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"issue":"34 Suppl","key":"10.1016\/j.pcad.2019.05.006_bb0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1054\/jelc.2001.28865","article-title":"Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children","author":"Antzelevitch","year":"2001","journal-title":"J Electrocardiol"},{"issue":"14","key":"10.1016\/j.pcad.2019.05.006_bb0180","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.jacc.2019.01.048","article-title":"Characterization and management of arrhythmic events in young patients with Brugada syndrome","volume":"73","author":"Michowitz","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.pcad.2019.05.006_bb0185","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.117.027983","article-title":"Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese multicenter registry","volume":"135","author":"Yamagata","year":"2017","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.pcad.2019.05.006_bb0190","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/humu.21066","article-title":"The genetic basis of Brugada syndrome: a mutation update","volume":"30","author":"Hedley","year":"2009","journal-title":"Hum Mutat"},{"issue":"17","key":"10.1016\/j.pcad.2019.05.006_bb0195","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1161\/CIRCULATIONAHA.108.770917","article-title":"Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome","volume":"118","author":"Morita","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pcad.2019.05.006_bb0200","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.hrthm.2013.07.021","article-title":"Executive summary: HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/hc0102.101354","article-title":"Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3","volume":"105","author":"Brugada","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pcad.2019.05.006_bb0210","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/hc1102.105288","article-title":"Natural history of Brugada syndrome: insights for risk stratification and management","volume":"105","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.pcad.2019.05.006_bb0215","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/euhj.2002.3256","article-title":"Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats","volume":"23","author":"Eckardt","year":"2002","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pcad.2019.05.006_bb0225","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.109.887026","article-title":"Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry","volume":"121","author":"Probst","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pcad.2019.05.006_bb0230","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1540-8167.2006.00455.x","article-title":"Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis","volume":"17","author":"Gehi","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"12","key":"10.1016\/j.pcad.2019.05.006_bb0235","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.110.972612","article-title":"Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium","volume":"123","author":"Nademanee","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pcad.2019.05.006_bb0240","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"Leenhardt","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pcad.2019.05.006_bb0250","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia","volume":"103","author":"Priori","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.pcad.2019.05.006_bb0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/heartjnl-2012-302033","article-title":"Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside","volume":"99","author":"van der Werf","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2019.05.006_bb0260","unstructured":"Leenhardt A, Coumel P, Slama R. [Clinical aspects of polymorphic ventricular tachycardia]. Arch Mal Coeur Vaiss. 1992;85 Spec No 4:23\u20139."},{"issue":"18","key":"10.1016\/j.pcad.2019.05.006_bb0265","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pcad.2019.05.006_bb0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/heart.89.1.66","article-title":"Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death","volume":"89","author":"Sumitomo","year":"2003","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.pcad.2019.05.006_bb0275","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.joa.2015.09.008","article-title":"Current topics in catecholaminergic polymorphic ventricular tachycardia","volume":"32","author":"Sumitomo","year":"2016","journal-title":"J Arrhythm"},{"issue":"22","key":"10.1016\/j.pcad.2019.05.006_bb0280","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.pcad.2019.05.006_bb0285","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: a systematic review","volume":"15","author":"Roston","year":"2018","journal-title":"Heart Rhythm"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019300817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019300817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:17:10Z","timestamp":1758500230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062019300817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0033062019300817"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2019.05.006","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT)","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}